Evidence map›Paper›PMID 31233891›Full record

ArticleActa biomaterialia2019

3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels.

Peter A Mollica, Elizabeth N Booth-Creech, John A Reid, Martina Zamponi, Shea M Sullivan, Xavier-Lewis Palmer, Patrick C Sachs, Robert D Bruno

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 194 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. 3D bioprinting innovations: a new frontier in breast cancer research.Medical oncology (Northwood, London, England) · 2025
    Review
  9. Review
  10. A review of 3D bioprinting for organoids.Medical review (2021) · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Organoids in breast cancer translational research: intersection of technologies.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2025
    Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Peter A MollicaSchool of Medical Diagnostic and Translational Sciences, Old Dominion University, Norfolk, VA 23529, USA; Molecular Diagnostics Laboratory, Sentara Norfolk General Hospital, Norfolk, VA 23507, USA. Electronic address: pmollica@odu.edu.
Elizabeth N Booth-CreechSchool of Medical Diagnostic and Translational Sciences, Old Dominion University, Norfolk, VA 23529, USA; Biomedical Sciences Graduate Program, Eastern Virginia Medical School, Norfolk, VA 23501, USA.
John A ReidSchool of Medical Diagnostic and Translational Sciences, Old Dominion University, Norfolk, VA 23529, USA; Biomedical Engineering Institute, Old Dominion University, Norfolk, VA 23529, USA. Electronic address: jreid028@odu.edu.
Martina ZamponiSchool of Medical Diagnostic and Translational Sciences, Old Dominion University, Norfolk, VA 23529, USA; Biomedical Engineering Institute, Old Dominion University, Norfolk, VA 23529, USA. Electronic address: mzamp001@odu.edu.
Shea M SullivanSchool of Medical Diagnostic and Translational Sciences, Old Dominion University, Norfolk, VA 23529, USA; Eastern Virginia Medical School, Norfolk, VA 23501, USA.
Xavier-Lewis PalmerSchool of Medical Diagnostic and Translational Sciences, Old Dominion University, Norfolk, VA 23529, USA; Biomedical Engineering Institute, Old Dominion University, Norfolk, VA 23529, USA. Electronic address: xpalm001@odu.edu.
Patrick C SachsSchool of Medical Diagnostic and Translational Sciences, Old Dominion University, Norfolk, VA 23529, USA. Electronic address: psachs@odu.edu.
Robert D BrunoSchool of Medical Diagnostic and Translational Sciences, Old Dominion University, Norfolk, VA 23529, USA. Electronic address: rbruno@odu.edu.
Old Dominion University · US

Funding

A three dimensional bioprinting approach to mapping critical determinants of stem cell asymmetric divisionsR15GM131330 · NIGMS · OLD DOMINION UNIVERSITY · PI BRUNO, ROBERT, SACHS, PATRICK CHRISTIAN · 2019 to 2019
$451k
NIGMS NIH HHS R15 GM131330
6 · The paper itself

Abstract

The extracellular matrix (ECM) of tissues is an important mediator of cell function. Moreover, understanding cellular dynamics within their specific tissue context is also important for developmental biology, cancer research, and regenerative medicine. However, robust in vitro models that incorporate tissue-specific microenvironments are lacking. Here we describe a novel mammary-specific culture protocol that combines a self-gelling hydrogel comprised solely of ECM from decellularized rat or human breast tissue with the use of our previously described 3D bioprinting platform. We initially demonstrate that undigested and decellularized mammary tissue can support mammary epithelial and tumor cell growth. We then describe a methodology for generating mammary ECM extracts that can spontaneously gel to form hydrogels. These ECM hydrogels retain unique structural and signaling profiles that elicit differential responses when normal mammary and breast cancer cells are cultured within them. Using our bioprinter, we establish that we can generate large organoids/tumoroids in the all mammary-derived hydrogel. These findings demonstrate that our system allows for growth of organoids/tumoroids in a tissue-specific matrix with unique properties, thus providing a suitable platform for ECM and epithelial/cancer cell studies. STATEMENT OF SIGNIFICANCE: Factors within extracellular matrices (ECMs) are specific to their tissue of origin. It has been shown that tissue specific factors within the mammary gland's ECM have pronounced effects on cellular differentiation and cancer behavior. Understanding the role of the ECM in controlling cell fate has major implications for developmental biology, tissue engineering, and cancer therapy. However, in vitro models to study cellular interactions with tissue specific ECM are lacking. Here we describe the generation of 3D hydrogels consisting solely of human or mouse mammary ECM. We demonstrate that these novel 3D culture substrates can sustain large 3D bioprinted organoid and tumoroid formation. This is the first demonstration of an all mammary ECM culture system capable of sustaining large structural growths.

Indexed as

BioprintingPrinting, Three-DimensionalAnimalsBreast NeoplasmsCell Line, TumorExtracellular MatrixFemaleHumansHydrogelsIntercellular Signaling Peptides and ProteinsKeratin-5Ki-67 AntigenMammary Glands, HumanOrganoidsRatsSignal TransductionHydrogelsIntercellular Signaling Peptides and ProteinsKeratin-5Ki-67 Antigen3D bioprintingMammary ECMMicroenvironmentOrganoidsTumoroids

Identifiers

PMID31233891
PMCPMC6710129
OpenAlexW2949422228

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.